Explore the full directors' dealings record of 알리코제약, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 알리코제약 has published 21 insider filings. The latest transaction was disclosed on 26 May 2026 (Sale). Among the most active insiders: 이항구. The full history is accessible without an account.
21
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
13 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.